The apoptosis assay market is growing rapidly due to innovations in biotechnology, rising healthcare needs, and the increasing focus on personalized medicine, especially in oncology and ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

UCLA researchers have developed a new approach to treating glioblastoma by combining genetic and functional profiling to ...

There are approx. 25+ key companies which are developing the therapies for Cutaneous T-cell lymphoma. The companies which have their Cutaneous T-cell lymphoma drug candidates in the most advanced ...

In this valuable study, the authors used an elegant genetic approach to delete EED at the post-neural crest induction stage. The usage of the single-cell RNA-seq analysis method is extremely suitable ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

In this study, our results uncover the function and mechanism of CHMP5 in the regulation of cell senescence and bone formation in osteogenic cells. Deletion of Chmp5 causes endolysosomal dysfunction ...

Glioblastoma is notoriously difficult to treat due to its ability to resist cell death, a process known as apoptosis, and its rapid adaptation to therapies ... The researchers then tested a new ...

It enables the simultaneous assessment of multiple parameters, such as cell surface and intracellular molecules, using ...